Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mineral metabolism: Should cinacalcet be used in patients who are not on dialysis?

Literature DB >> 19474823

Mineral metabolism: Should cinacalcet be used in patients who are not on dialysis?

Jorge B Cannata-Andía, José L Fernández-Martín.

Abstract

Cinacalcet is an effective treatment for secondary hyperparathyroidism in patients on dialysis. Until now, no randomized, placebo-controlled, long-term trial has tested this drug in individuals with chronic kidney disease who are not receiving dialysis.

Entities: Chemical Disease Species

Mesh：

Substances：
Naphthalenes
Cinacalcet

Year: 2009 PMID： 19474823 DOI： 10.1038/nrneph.2009.54

Source DB: PubMed Journal: Nat Rev Nephrol ISSN： 1759-5061 Impact factor: 28.314

11 in total

1. Serum phosphate levels and mortality risk among people with chronic kidney disease.

Authors: Bryan Kestenbaum; Joshua N Sampson; Kyle D Rudser; Donald J Patterson; Stephen L Seliger; Bessie Young; Donald J Sherrard; Dennis L Andress
Journal: J Am Soc Nephrol Date: 2004-12-22 Impact factor: 10.121

2. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

Authors: Daniel Coyne; Muralidhar Acharya; Ping Qiu; Hanna Abboud; Daniel Batlle; Steven Rosansky; Stephen Fadem; Barton Levine; Laura Williams; Dennis L Andress; Stuart M Sprague
Journal: Am J Kidney Dis Date: 2006-02 Impact factor: 8.860

3. Oral active vitamin D is associated with improved survival in hemodialysis patients.

Authors: Manuel Naves-Díaz; Daniel Alvarez-Hernández; Jutta Passlick-Deetjen; Adrian Guinsburg; Cristina Marelli; Diego Rodriguez-Puyol; Jorge B Cannata-Andía
Journal: Kidney Int Date: 2008-07-16 Impact factor: 10.612

4. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.

Authors: K Kalantar-Zadeh; N Kuwae; D L Regidor; C P Kovesdy; R D Kilpatrick; C S Shinaberger; C J McAllister; M J Budoff; I B Salusky; J D Kopple
Journal: Kidney Int Date: 2006-07-05 Impact factor: 10.612

5. Antiproteinuric effect of oral paricalcitol in chronic kidney disease.

Authors: Rajiv Agarwal; Muralidhar Acharya; Jin Tian; Richard L Hippensteel; Joel Z Melnick; Ping Qiu; Laura Williams; Daniel Batlle
Journal: Kidney Int Date: 2005-12 Impact factor: 10.612

6. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

Authors: Orlando Gutierrez; Tamara Isakova; Eugene Rhee; Anand Shah; Julie Holmes; Gina Collerone; Harald Jüppner; Myles Wolf
Journal: J Am Soc Nephrol Date: 2005-05-25 Impact factor: 10.121

7. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.

Authors: Andreas L Serra; Claudia Wuhrmann; Rudolf P Wüthrich
Journal: Am J Kidney Dis Date: 2008-10-31 Impact factor: 8.860

8. Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells.

Authors: Masih-ul Alam; John Paul Kirton; Fiona L Wilkinson; Emily Towers; Smeeta Sinha; Mansour Rouhi; Thomas N Vizard; Andrew P Sage; David Martin; Donald T Ward; Marie Yvonne Alexander; Daniela Riccardi; Ann E Canfield
Journal: Cardiovasc Res Date: 2008-10-13 Impact factor: 10.787

9. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.

Authors: Michel Chonchol; Francesco Locatelli; Hanna E Abboud; Chaim Charytan; Angel L M de Francisco; Shivinder Jolly; Mark Kaplan; Simon D Roger; Shyamal Sarkar; Moetaz B Albizem; T Christian H Mix; Yumi Kubo; Geoffrey A Block
Journal: Am J Kidney Dis Date: 2008-12-24 Impact factor: 8.860

10. Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism.

Authors: Mario Meola; Ilaria Petrucci; Giuliano Barsotti
Journal: Nephrol Dial Transplant Date: 2009-01-30 Impact factor: 5.992

4 in total